Chris has served as a C-level executive of various private and public life sciences, medical technology, and technology companies. Chris has successfully raised over $1B in financing, completed $1.4B in M&A transactions, completed four NASDAQ IPOs, and served as the founding Managing Partner of a diversified early-stage venture fund with over $250 million AUM.
Chris has worked successfully within the angel investing, venture, and private equity community for over 20 years.
